ACM
DFTX

Aquatic Capital Management’s Definium Therapeutics DFTX Stock Holding History

Aquatic Capital Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Buy
+43,124
New +$1.07M 0.07% 359
2024
Q3 		– Sell
-6,600
Closed -$47.6K – 1397
2024
Q2 		$47.6K Buy
+6,600
New +$57.7K ﹤0.01% 1019

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Aquatic Capital Management's DFTX Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 43,124 shares worth $2.03M. The stake represents 0.07% of the portfolio and ranks #359 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in DFTX as recently as Q2 2024.

Aquatic Capital Management first reported a position in DFTX in Q2 2024 and has held it in 2 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Aquatic Capital Management held 43,124 shares of Definium Therapeutics worth $2.03M as of Q2 2026.
  • Definium Therapeutics was a new Aquatic Capital Management position in Q2 2026.
  • Definium Therapeutics made up 0.07% of Aquatic Capital Management's portfolio in Q2 2026, its #359 holding.
  • Aquatic Capital Management first reported a position in Definium Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.